Pharvaris (PHVS) Stock Chart & Stock Price History $17.42 -0.19 (-1.05%) As of 01:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pharvaris Stock Price Performance The Pharvaris (PHVS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 6.82%, with a year-to-date return of -9.15%. In the past month, the stock has increased 5.35%, reflecting recent market activity. As of the latest close, Pharvaris traded at $17.60 with a market cap of $920.30 million and volume of 85,320 shares. Receive PHVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.71%1 Month Performance+5.35%3 Month Performance+17.43%Year-To-Date Performance-9.15%1 Year Performance-6.82% PHVS Stock Chart for Tuesday, July, 1, 2025 PHVS Chart by TradingView Pharvaris Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$17.00$17.60+3.53%$17.80$16.8085,320 shs$920.30 million06/27/2025$17.90$17.00-5.03%$18.00$16.7833,521 shs$888.93 million06/26/2025$17.56$17.90+1.94%$18.00$17.1221,080 shs$935.99 million06/25/2025$17.20$17.56+2.09%$17.58$16.7811,609 shs$918.21 million06/24/2025$17.42$17.20-1.26%$17.74$17.1622,168 shs$899.39 million06/23/2025$17.99$17.42-3.17%$18.00$16.9522,188 shs$910.89 million06/20/2025$16.64$17.99+8.11%$18.00$17.0562,025 shs$940.70 million06/19/2025$16.64$16.64$17.19$16.006,244 shs$870.11 million06/18/2025$16.56$16.64+0.48%$17.19$16.006,244 shs$870.11 million06/17/2025$16.96$16.56-2.36%$16.73$16.566,420 shs$865.92 million Get the Latest News and Ratings for PHVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$16.70$16.96+1.56%$16.96$16.3111,256 shs$886.84 million06/13/2025$17.23$16.70-3.08%$17.53$16.4512,409 shs$873.24 million06/12/2025$17.05$17.23+1.06%$17.23$16.386,095 shs$900.96 million06/11/2025$18.12$17.05-5.91%$19.39$17.0537,761 shs$891.54 million06/10/2025$18.03$18.12+0.50%$19.06$17.5173,333 shs$947.50 million06/09/2025$16.78$18.03+7.45%$18.34$16.3664,706 shs$942.79 million06/06/2025$16.05$16.78+4.55%$17.19$15.9982,545 shs$877.43 million06/05/2025$16.62$16.05-3.43%$16.88$15.9181,019 shs$839.25 million06/04/2025$17.28$16.62-3.82%$17.30$16.5767,922 shs$869.06 million06/03/2025$16.49$17.28+4.79%$18.00$16.42156,686 shs$903.57 million06/02/2025$16.53$16.49-0.24%$16.88$16.20110,708 shs$862.26 million05/30/2025$16.72$16.53-1.14%$16.99$16.26189,848 shs$864.35 million Related Companies Merus Stock Price Chart SpringWorks Therapeutics Stock Price Chart Avidity Biosciences Stock Price Chart Ultragenyx Pharmaceutical Stock Price Chart Arcellx Stock Price Chart Protagonist Therapeutics Stock Price Chart Ascentage Pharma Group International Stock Price Chart Scholar Rock Stock Price Chart Metsera Stock Price Chart Kymera Therapeutics Stock Price Chart Receive PHVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PHVS) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredFine. Don’t believe me. They called me an alarmist... When in 2010 I said America’s debt was out of control. When I warned it w...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharvaris N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharvaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
